Global RDT (Rapid Diagnostic Test) COVID-19 Test Kit Market Growth 2023-2029

Global RDT (Rapid Diagnostic Test) COVID-19 Test Kit Market Growth 2023-2029

COVID-19 antigen rapid detection kit is a qualitative side flow immunochromatographic assay, which is mainly used to detect SARS CoV-2 antigen in human pharynx, nose and nasopharynx swabs. The kit contains monoclonal antibodies against SARS CoV-2/COVID-19. The capture antibody is coupled with gold labeled nanoparticles and can capture any SARS CoV-2 antigen in the sample."

LPI (LP Information)' newest research report, the “RDT (Rapid Diagnostic Test) COVID-19 Test Kit Industry Forecast” looks at past sales and reviews total world RDT (Rapid Diagnostic Test) COVID-19 Test Kit sales in 2022, providing a comprehensive analysis by region and market sector of projected RDT (Rapid Diagnostic Test) COVID-19 Test Kit sales for 2023 through 2029. With RDT (Rapid Diagnostic Test) COVID-19 Test Kit sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world RDT (Rapid Diagnostic Test) COVID-19 Test Kit industry.

This Insight Report provides a comprehensive analysis of the global RDT (Rapid Diagnostic Test) COVID-19 Test Kit landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on RDT (Rapid Diagnostic Test) COVID-19 Test Kit portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global RDT (Rapid Diagnostic Test) COVID-19 Test Kit market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for RDT (Rapid Diagnostic Test) COVID-19 Test Kit and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global RDT (Rapid Diagnostic Test) COVID-19 Test Kit.

The global RDT (Rapid Diagnostic Test) COVID-19 Test Kit market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for RDT (Rapid Diagnostic Test) COVID-19 Test Kit is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for RDT (Rapid Diagnostic Test) COVID-19 Test Kit is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for RDT (Rapid Diagnostic Test) COVID-19 Test Kit is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key RDT (Rapid Diagnostic Test) COVID-19 Test Kit players cover Cellex, RayBiotech, Biopanda, BioMedomics, GenBody, SD Biosensor, Advaite, Premier Biotech and Epitope Diagnostics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of RDT (Rapid Diagnostic Test) COVID-19 Test Kit market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Blood Test
Saliva Test
Others

Segmentation by application
Hospital
Scientific Research
Diagnostic Center

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Cellex
RayBiotech
Biopanda
BioMedomics
GenBody
SD Biosensor
Advaite
Premier Biotech
Epitope Diagnostics
CTK Biotech
Creative Diagnostics
Eagle Biosciences
Sure Biotech
Sugentech
Sensing self
Euroimmun AG

Key Questions Addressed in this Report

What is the 10-year outlook for the global RDT (Rapid Diagnostic Test) COVID-19 Test Kit market?

What factors are driving RDT (Rapid Diagnostic Test) COVID-19 Test Kit market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do RDT (Rapid Diagnostic Test) COVID-19 Test Kit market opportunities vary by end market size?

How does RDT (Rapid Diagnostic Test) COVID-19 Test Kit break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.